Amlodipine/indapamide/telmisartan - George Medicines
Alternative Names: GMRx2; Indapamide/amlodipine/telmisartan - George Medicines; Telmisartan/amlodipine/indapamide - George MedicinesLatest Information Update: 03 Sep 2024
At a glance
- Originator George Medicines
- Class Antihypertensives; Benzimidazoles; Benzoates; Dihydropyridines; Indoles; Ischaemic heart disorder therapies; Small molecules; Sulfonamides
- Mechanism of Action ACE inhibitors; Angiotensin type 1 receptor antagonists; Calcium channel antagonists; Thiazide-like diuretics
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Preregistration Hypertension
Most Recent Events
- 31 Aug 2024 Efficacy and adverse events data from a phase III GMRx2_PCT trial in Hypertension released by George Medicines
- 31 Aug 2024 Efficacy and adverse events data from a VERONICA clinical trial in Hypertension released by George Medicines
- 31 Aug 2024 Efficacy and adverse events data from a phase III trial in Hypertension released by George Medicines